We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MSC:NYSEStudio City International Holdings Limited Analysis

Data as of 2026-08-22 - not real-time

$1.86

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Studio City International Holdings Limited trades at $1.85, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. It has gained 5.7% over the past 30 days. With RSI at 52.6 the momentum picture is neutral, alongside a bullish MACD signal. Recent trading has carved out support near $1.57 and resistance around $3.01.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is contracting at 13.4% on a -7.6% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 83.4%, a beta of -0.91 and a maximum drawdown of 66.7%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on sell, with conviction of 4/10.

Top Market Events

MACAU, Aug. 07, 2026 GLOBE NEWSWIRE -- Studio City International Holdings Limited NYSE: MSC , a world-class integrated...MACAU, Aug. 13, 2026 GLOBE NEWSWIRE -- Studio City International Holdings Limited NYSE: MSC "Studio City" or the...Enid News & Eagle15dStudio City Announces Earnings Release DateMACAU, Aug.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 2.72
  • MACD momentum is positive

Medium Term

1–3 years
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 2.72
  • 30-day volatility of 83.4%

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Negative profit margin of -7.6%
  • Negative return on equity of -10.2%
  • Revenue contracting at -13.4%

Key Metrics & Analysis

Financial Health

Revenue Growth-13.40%
Profit Margin-7.57%
P/E Ratio-18.6
ROE-10.17%
ROA1.70%
Debt/Equity374.96
P/B Ratio0.8

Technical Analysis

TrendBearish
RSI52.6
Support$1.57
Resistance$3.01
MA 20$1.79
MA 50$1.85
MA 200$2.72
MACDBullish
VolumeDecreasing
Fear & Greed Index94.41

Valuation

GradeFair
TypeBlend

Risk Assessment

Beta-0.91
Volatility83.37%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.